Ligand validation:5U93

RM4: beta-L-rhamnopyranose

RM4 is a Ligand Of Interest in 5U93 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5U93_RM4_A_502	95%	42%	0.059	0.96	1.29	0.99	-	-	0	0	100%	1
5U93_RM4_B_202	88%	36%	0.074	0.949	1.45	1.07	2	1	0	0	100%	1
5U9E_RM4_B_301	33%	18%	0.277	0.959	1.59	1.92	3	5	3	0	100%	0.76
6RGR_RM4_A_403	96%	68%	0.06	0.97	0.42	0.82	-	-	0	0	100%	1
6IFB_RM4_B_201	92%	52%	0.066	0.954	1	0.85	-	-	0	0	100%	1
8JQ4_RM4_D_503	87%	80%	0.081	0.951	0.22	0.61	-	-	0	0	100%	1
4GJI_RM4_B_501	72%	81%	0.112	0.934	0.36	0.45	-	-	2	0	100%	0.5
2QLX_RM4_B_300	64%	55%	0.12	0.917	0.93	0.83	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.